Manufacturing - Tools & Accessories
Compare Stocks
5 / 10Stock Comparison
CVR vs NVT vs STLD vs ETN vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Electrical Equipment & Parts
Steel
Industrial - Machinery
Industrial - Machinery
CVR vs NVT vs STLD vs ETN vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Manufacturing - Tools & Accessories | Electrical Equipment & Parts | Steel | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $11M | $26.96B | $33.75B | $155.02B | $79.02B |
| Revenue (TTM) | $28M | $4.33B | $19.01B | $28.52B | $18.32B |
| Net Income (TTM) | $-1M | $492M | $1.37B | $3.99B | $2.44B |
| Gross Margin | 14.8% | 37.0% | 14.0% | 36.9% | 52.7% |
| Operating Margin | -5.5% | 15.8% | 9.4% | 18.1% | 19.8% |
| Forward P/E | — | 39.7x | 15.6x | 30.0x | 21.7x |
| Total Debt | $921K | $1.56B | $4.21B | $11.17B | $13.76B |
| Cash & Equiv. | $2M | $238M | $770M | $622M | $1.54B |
CVR vs NVT vs STLD vs ETN vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Chicago Rivet & Mac… (CVR) | 100 | 55.6 | -44.4% |
| nVent Electric plc (NVT) | 100 | 909.6 | +809.6% |
| Steel Dynamics, Inc. (STLD) | 100 | 877.0 | +777.0% |
| Eaton Corporation p… (ETN) | 100 | 470.2 | +370.2% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CVR vs NVT vs STLD vs ETN vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CVR ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.97, Low D/E 4.9%, current ratio 5.21x
- Beta 0.97, yield 1.1%, current ratio 5.21x
- Beta 0.97 vs NVT's 1.68, lower leverage
NVT has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 29.5%, EPS growth 118.8%, 3Y rev CAGR 19.3%
- 29.5% revenue growth vs EMR's 3.0%
- +178.6% vs CVR's +3.7%
STLD is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 9.4% 10Y total return vs NVT's 5.8%
- PEG 0.62 vs EMR's 4.81
- Lower P/E (15.6x vs 30.0x), PEG 0.62 vs 1.22
ETN is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 14.0% margin vs CVR's -3.9%
- 9.0% ROA vs CVR's -4.6%, ROIC 13.6% vs -6.4%
EMR is the clearest fit if your priority is income & stability.
- Dividend streak 37 yrs, beta 1.52, yield 1.5%
- 1.5% yield, 37-year raise streak, vs STLD's 0.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 29.5% revenue growth vs EMR's 3.0% | |
| Value | Lower P/E (15.6x vs 30.0x), PEG 0.62 vs 1.22 | |
| Quality / Margins | 14.0% margin vs CVR's -3.9% | |
| Stability / Safety | Beta 0.97 vs NVT's 1.68, lower leverage | |
| Dividends | 1.5% yield, 37-year raise streak, vs STLD's 0.8% | |
| Momentum (1Y) | +178.6% vs CVR's +3.7% | |
| Efficiency (ROA) | 9.0% ROA vs CVR's -4.6%, ROIC 13.6% vs -6.4% |
CVR vs NVT vs STLD vs ETN vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CVR vs NVT vs STLD vs ETN vs EMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMR leads in 2 of 6 categories
CVR leads 1 • ETN leads 1 • NVT leads 1 • STLD leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ETN is the larger business by revenue, generating $28.5B annually — 1022.7x CVR's $28M. ETN is the more profitable business, keeping 14.0% of every revenue dollar as net income compared to CVR's -3.9%. On growth, NVT holds the edge at +53.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $28M | $4.3B | $19.0B | $28.5B | $18.3B |
| EBITDAEarnings before interest/tax | -$318,590 | $848M | $2.4B | $5.9B | $4.7B |
| Net IncomeAfter-tax profit | -$1M | $492M | $1.4B | $4.0B | $2.4B |
| Free Cash FlowCash after capex | -$2M | $387M | $665M | $4.7B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +14.8% | +37.0% | +14.0% | +36.9% | +52.7% |
| Operating MarginEBIT ÷ Revenue | -5.5% | +15.8% | +9.4% | +18.1% | +19.8% |
| Net MarginNet income ÷ Revenue | -3.9% | +11.4% | +7.2% | +14.0% | +13.3% |
| FCF MarginFCF ÷ Revenue | -5.6% | +8.9% | +3.5% | +16.5% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +45.9% | +53.5% | +19.1% | +16.8% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +67.9% | -59.7% | +93.1% | -9.4% | +28.2% |
Valuation Metrics
CVR leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 29.2x trailing earnings, STLD trades at a 25% valuation discount to NVT's 38.7x P/E. Adjusting for growth (PEG ratio), STLD offers better value at 1.15x vs EMR's 7.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11M | $27.0B | $33.7B | $155.0B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $10M | $28.3B | $37.2B | $165.6B | $91.2B |
| Trailing P/EPrice ÷ TTM EPS | -9.73x | 38.68x | 29.15x | 38.17x | 34.92x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 39.70x | 15.64x | 30.00x | 21.71x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.15x | 1.55x | 7.73x |
| EV / EBITDAEnterprise value multiple | — | 34.30x | 18.34x | 27.69x | 18.07x |
| Price / SalesMarket cap ÷ Revenue | 0.38x | 6.93x | 1.86x | 5.65x | 4.39x |
| Price / BookPrice ÷ Book value/share | 0.56x | 7.36x | 3.87x | 7.99x | 3.94x |
| Price / FCFMarket cap ÷ FCF | — | 72.49x | 67.29x | 34.67x | 29.63x |
Profitability & Efficiency
ETN leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ETN delivers a 20.8% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-5 for CVR. CVR carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMR's 0.68x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs STLD's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.5% | +13.4% | +15.3% | +20.8% | +12.1% |
| ROA (TTM)Return on assets | -4.6% | +7.2% | +8.5% | +9.0% | +5.8% |
| ROICReturn on invested capital | -6.4% | +8.9% | +9.2% | +13.6% | +8.2% |
| ROCEReturn on capital employed | -7.3% | +10.5% | +10.9% | +16.8% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.05x | 0.42x | 0.47x | 0.57x | 0.68x |
| Net DebtTotal debt minus cash | -$797,274 | $1.3B | $3.4B | $10.5B | $12.2B |
| Cash & Equiv.Liquid assets | $2M | $238M | $770M | $622M | $1.5B |
| Total DebtShort + long-term debt | $920,963 | $1.6B | $4.2B | $11.2B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | — | 6.61x | 20.39x | 16.38x | 6.46x |
Total Returns (Dividends Reinvested)
NVT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVT five years ago would be worth $53,671 today (with dividends reinvested), compared to $5,180 for CVR. Over the past 12 months, NVT leads with a +178.6% total return vs CVR's +3.7%. The 3-year compound annual growth rate (CAGR) favors NVT at 59.8% vs CVR's -23.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -21.9% | +56.5% | +32.6% | +22.3% | +4.3% |
| 1-Year ReturnPast 12 months | +3.7% | +178.6% | +79.8% | +33.2% | +30.4% |
| 3-Year ReturnCumulative with dividends | -54.9% | +308.2% | +143.7% | +141.3% | +75.9% |
| 5-Year ReturnCumulative with dividends | -48.2% | +436.7% | +280.6% | +182.8% | +59.5% |
| 10-Year ReturnCumulative with dividends | -27.5% | +576.7% | +940.9% | +608.7% | +206.6% |
| CAGR (3Y)Annualised 3-year return | -23.3% | +59.8% | +34.6% | +34.1% | +20.7% |
Risk & Volatility
Evenly matched — CVR and STLD each lead in 1 of 2 comparable metrics.
Risk & Volatility
CVR is the less volatile stock with a 0.97 beta — it tends to amplify market swings less than NVT's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. STLD currently trades 95.6% from its 52-week high vs CVR's 72.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.97x | 1.68x | 1.32x | 1.42x | 1.52x |
| 52-Week HighHighest price in past year | $15.00 | $174.50 | $243.72 | $435.43 | $165.15 |
| 52-Week LowLowest price in past year | $8.15 | $59.73 | $119.89 | $296.93 | $108.37 |
| % of 52W HighCurrent price vs 52-week peak | +72.7% | +95.5% | +95.6% | +91.7% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 49.4 | 82.3 | 81.6 | 59.8 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 3K | 2.3M | 1.1M | 2.5M | 2.8M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NVT as "Buy", STLD as "Buy", ETN as "Buy", EMR as "Buy". Consensus price targets imply 14.8% upside for EMR (target: $162) vs -19.6% for NVT (target: $134). For income investors, EMR offers the higher dividend yield at 1.49% vs NVT's 0.48%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $134.00 | $188.40 | $379.78 | $161.92 |
| # AnalystsCovering analysts | — | 17 | 27 | 39 | 41 |
| Dividend YieldAnnual dividend ÷ price | +1.1% | +0.5% | +0.8% | +1.0% | +1.5% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 15 | 24 | 37 |
| Dividend / ShareAnnual DPS | $0.12 | $0.79 | $1.96 | $4.17 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.9% | +2.7% | +1.2% | +1.6% |
EMR leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). CVR leads in 1 (Valuation Metrics). 1 tied.
CVR vs NVT vs STLD vs ETN vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CVR or NVT or STLD or ETN or EMR a better buy right now?
For growth investors, nVent Electric plc (NVT) is the stronger pick with 29.
5% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Steel Dynamics, Inc. (STLD) offers the better valuation at 29. 2x trailing P/E (15. 6x forward), making it the more compelling value choice. Analysts rate nVent Electric plc (NVT) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CVR or NVT or STLD or ETN or EMR?
On trailing P/E, Steel Dynamics, Inc.
(STLD) is the cheapest at 29. 2x versus nVent Electric plc at 38. 7x. On forward P/E, Steel Dynamics, Inc. is actually cheaper at 15. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Steel Dynamics, Inc. wins at 0. 62x versus Emerson Electric Co. 's 4. 81x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CVR or NVT or STLD or ETN or EMR?
Over the past 5 years, nVent Electric plc (NVT) delivered a total return of +436.
7%, compared to -48. 2% for Chicago Rivet & Machine Co. (CVR). Over 10 years, the gap is even starker: STLD returned +940. 9% versus CVR's -27. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CVR or NVT or STLD or ETN or EMR?
By beta (market sensitivity over 5 years), Chicago Rivet & Machine Co.
(CVR) is the lower-risk stock at 0. 97β versus nVent Electric plc's 1. 68β — meaning NVT is approximately 72% more volatile than CVR relative to the S&P 500. On balance sheet safety, Chicago Rivet & Machine Co. (CVR) carries a lower debt/equity ratio of 5% versus 68% for Emerson Electric Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CVR or NVT or STLD or ETN or EMR?
By revenue growth (latest reported year), nVent Electric plc (NVT) is pulling ahead at 29.
5% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: nVent Electric plc grew EPS 118. 8% year-over-year, compared to -18. 8% for Steel Dynamics, Inc.. Over a 3-year CAGR, NVT leads at 19. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CVR or NVT or STLD or ETN or EMR?
nVent Electric plc (NVT) is the more profitable company, earning 18.
2% net margin versus -3. 9% for Chicago Rivet & Machine Co. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus -5. 5% for CVR. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CVR or NVT or STLD or ETN or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Steel Dynamics, Inc. (STLD) is the more undervalued stock at a PEG of 0. 62x versus Emerson Electric Co. 's 4. 81x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Steel Dynamics, Inc. (STLD) trades at 15. 6x forward P/E versus 39. 7x for nVent Electric plc — 24. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 8% to $161. 92.
08Which pays a better dividend — CVR or NVT or STLD or ETN or EMR?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 5%, versus 0. 5% for nVent Electric plc (NVT).
09Is CVR or NVT or STLD or ETN or EMR better for a retirement portfolio?
For long-horizon retirement investors, Steel Dynamics, Inc.
(STLD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0. 8% yield, +940. 9% 10Y return). nVent Electric plc (NVT) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (STLD: +940. 9%, NVT: +576. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CVR and NVT and STLD and ETN and EMR?
These companies operate in different sectors (CVR (Industrials) and NVT (Industrials) and STLD (Basic Materials) and ETN (Industrials) and EMR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CVR is a small-cap quality compounder stock; NVT is a mid-cap high-growth stock; STLD is a mid-cap quality compounder stock; ETN is a mid-cap quality compounder stock; EMR is a mid-cap quality compounder stock. CVR, STLD, ETN, EMR pay a dividend while NVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.